.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Hepatoprotective regimens during chemotherapy are common in clinical practice. Clinicians often prescribe S-adenosylmethionine (SAMe) to manage liver injury. However, recent research highlights potential risks regarding SAMe breast cancer outcomes. A retrospective cohort study evaluated 1013 women treated for primary breast cancer. Therefore, doctors must balance hepatoprotection with oncologic safety.
The study found that SAMe exposure correlates with shorter overall survival. Moreover, disease-free survival rates were lower in patients receiving SAMe. Using ROC analysis, the team identified a critical threshold for exposure duration. Patients receiving more than four cycles of SAMe faced significant clinical risks. Consequently, high exposure levels more than doubled the hazard for death and disease recurrence.
Why does prolonged exposure impact SAMe breast cancer outcomes negatively? Transcriptomic data suggest that SAMe acts as a universal methyl donor. Increased intratumoral SAMe levels promote specific methylation signals like m6A, m5C, and m7G. Additionally, high METTL3 and METTL14 expression levels may drive tumor progression. These epigenetic changes potentially foster chemoresistance within the tumor microenvironment. Therefore, the biochemical role of SAMe might inadvertently support tumor survival during chemotherapy.
Doctors should reconsider long-term SAMe use for hepatoprotection during chemotherapy. Instead, they might explore alternative regimens that do not interfere with tumor epigenetics. Furthermore, monitoring the duration of supplement use is essential for patient safety. While liver protection remains a priority, maintaining oncologic efficacy is paramount. Further prospective studies will clarify these metabolic interactions in various cancer subtypes.
Prolonged exposure to SAMe, specifically beyond four cycles, is associated with shorter survival and a higher likelihood of cancer recurrence due to epigenetic alterations.
Yes, higher levels of intratumoral SAMe correlate with increased METTL3 and METTL14 expression, which drive RNA methylation pathways linked to poorer prognosis.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study warns that prolonged S-adenosylmethionine (SAMe) use during breast cancer chemotherapy may reduce survival and treatment response....
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
